Gene · 5355
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the structures, functions and mechanisms of epithelial membrane protein family in human cancers. | Exp Hematol Oncol | 2022 | 36217151 | PubTator, text mining | PubMed |
| Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma. | J Oncol | 2022 | 36213821 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation. | Cell Death Dis | 2022 | 36163342 | PubTator, text mining | PubMed |
| Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data. | Genes (Basel) | 2022 | 36140740 | PubTator, text mining | PubMed |
| Biofabrication of 3D breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors. | Biofabrication | 2022 | 36108605 | PubTator, text mining | PubMed |
| Evasion of interferon-mediated immune response by arteriviruses. | Front Immunol | 2022 | 36091073 | PubTator, text mining | PubMed |
| Potential therapeutic applications of infusions and hydroalcoholic extracts of Romanian glutinous sage (Salvia glutinosa L.). | Front Pharmacol | 2022 | 36059937 | PubTator, text mining | PubMed |
| Lentiviral vector-based xenograft tumors as candidate reference materials for detection of HER2-low breast cancer. | Front Oncol | 2022 | 36052254 | PubTator, text mining | PubMed |
| Delineating the activity of the potent nicotinic acetylcholine receptor agonists (+)-anatoxin-a and (-)-hosieine-A. | Acta Crystallogr F Struct Biol Commun | 2022 | 36048081 | PubTator, text mining | PubMed |
| Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19. | Antiviral Res | 2022 | 36041646 | PubTator, text mining | PubMed |
| Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms. | Front Pharmacol | 2022 | 36034860 | PubTator, text mining | PubMed |
| Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner. | Front Immunol | 2022 | 36032116 | PubTator, text mining | PubMed |
| [Construction and application of lentivirus overexpression vector with two labeling genes fused with CopGFP and PuroR]. | Zhongguo Ying Yong Sheng Li Xue Za Zhi | 2022 | 36031566 | PubTator, text mining | PubMed |
| Dengue virus NS4B protein as a target for developing antivirals. | Front Cell Infect Microbiol | 2022 | 36017362 | PubTator, text mining | PubMed |
Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades. | Pharmaceutics | 2022 | 36015186 | PubTator, text mining | PubMed |
| Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response. | Antioxidants (Basel) | 2022 | 36009267 | PubTator, text mining | PubMed |
| Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization. | iScience | 2022 | 35992305 | PubTator, text mining | PubMed |
| Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants. | Sci Rep | 2022 | 35987969 | PubTator, text mining | PubMed |
| Engineering an autonomous VH domain to modulate intracellular pathways and to interrogate the eIF4F complex. | Nat Commun | 2022 | 35982046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5355/papers?page=11